awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33556796-5672DB9A-5B18-44B5-85DA-6B018426ED58
Q33556796-5672DB9A-5B18-44B5-85DA-6B018426ED58
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33556796-5672DB9A-5B18-44B5-85DA-6B018426ED58
Rosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 years despite greater weight gain: observations from a Diabetes Outcome Progression Trial (ADOPT)
P2860
Q33556796-5672DB9A-5B18-44B5-85DA-6B018426ED58
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33556796-5672DB9A-5B18-44B5-85DA-6B018426ED58
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dee6d803a0f38df2235166cc866bfcfefc910226
P2860
Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.